Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
1984-8-13
|
pubmed:abstractText |
Antibody levels to 12 different pneumococcal capsular polysaccharides as well as the combined mean antibody level were measured in 19 patients with systemic lupus erythematosus (SLE) at 1, 2 and 3 years after immunization with a polyvalent pneumococcal vaccine and compared to 5 normal control subjects immunized at the same time. The mean levels in the 19 SLE patients were lower in all 3 years but the difference reached significance only in Year 1. At 3 years, 8 of the 19 SLE patients had levels below that considered to be protective and one such patient developed a pneumococcal pneumonia.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0315-162X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
11
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
306-8
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:6737372-Antibodies, Bacterial,
pubmed-meshheading:6737372-Bacterial Vaccines,
pubmed-meshheading:6737372-Humans,
pubmed-meshheading:6737372-Immunization,
pubmed-meshheading:6737372-Lupus Erythematosus, Systemic,
pubmed-meshheading:6737372-Polysaccharides, Bacterial,
pubmed-meshheading:6737372-Streptococcus pneumoniae,
pubmed-meshheading:6737372-Time Factors
|
pubmed:year |
1984
|
pubmed:articleTitle |
Persistence of pneumococcal antibodies after immunization in patients with systemic lupus erythematosus.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|